Impact of a Soluble Phospholipase A₂ Inhibitor on Inhaled Allergen Challenge in Subjects with Asthma

References

• Arbibe L, Koumanov K, Vial D, Rougeot C, Faure G, Havet N, Longacre S, Vargaftig B B, Bereziat G, Voelker D R, Wolf C, Touqui L. Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction. J Clin Invest 1998; 102(6):1152–1160. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Fonteh A N, Astumi G, LaPorte T, Chilton F H. Secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2 in murine bone marrow-derived mast cells. J Immunol 2000; 165(5):2773–2782. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Mehta D, Gupta S, Gaur S N, Gangal S V, Agrawal K P. Increased leukocyte phospholipase A2 activity and plasma lysophosphatidylcholine levels in asthma and rhinitis and their relationship to airway sensitivity to histamine. Am Rev Respir Dis 1990; 142(1):157–161. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Toyoshima M, Sato A, Taniguchi M, Imokawa S, Nakazawa K, Hayakawa H, Chida K. Serum phospholipase A2 activity in patients with aspirin-induced asthma. Nihon Kyobu Shikkan Gakkai Zasshi 1995; 33(7):691–694. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Touqui L, Herpin-Richard N, Gene R M, Jullian E, Aljabi D, Hamberger C, Vargaftig B B, Dessange J F. Excretion of platelet activating factor-acetylhydrolase and phospholipase A2 into nasal fluids after allergenicchallenge: possible role in the regulation of platelet activating factor release. J Allergy Clin Immunol 1994; 94(1):109–119. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Stadel J M, Hoyle K, Naclerio R M, Roshak A, Chilton F H. Characterization of phospholipase A2 from human nasal lavage. Am J Respir Cell Mol Biol 1994; 11(1):108–113. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bowton D L, Seeds M C, Fasano M B, Goldsmith B, Bass D A. Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics. Am J Respir Crit Care Med 1997; 155(2):421–425. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Chilton F H, Averill F J, Hubbard W C, Fonteh A N, Triggiani M, Liu M C. Antigen-induced generation of lyso-phospholipids in human airways. J Exp Med 1996; 183(5):2235–2245. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Dennis E A. The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem Sci 1997; 22(1):1–2. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Bull World Health Organ 2001; 79(4):373–374. [CSA]
   PubMed Web of Science ®Google Scholar
• National Heart Lung and Blood Institute of the National Institutes of Health. Guidelines for the Diagnosis and Management of Asthma. National Asthma Education and Prevention Program Expert Panel Report 2. NIH (NHLBI) Publication No. 97-4051 Bethesda, MD, 1997
   Google Scholar
• . Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152(3):1107–1136. [CSA]
   PubMed Web of Science ®Google Scholar
• Crapo R O, Morris A H, Gardner R M. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123(6):659–664. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Friedman B S, Bel E H, Buntinx A, Tanaka W, Han Y H, Shingo S, Spector R, Sterk P. Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses. Am Rev Respir Dis 1993; 147(4):839–844. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Grizzle J E. The two-period changeover design and its uses in clinical trials. Biometrics 1965; 21:467–480. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Koch G G. The use of non-parametric methods in the statistical analysis of the two-period changeover design. Biometrics 1972; 28(2):577–584. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Taublee J D. A note on the use of non-parametric methods in the statistical analysis of the two-period changeover design. Biometrics 1982; 38:1053–1055.
   Web of Science ®Google Scholar
• Hohlfeld J M, Ahlf K, Enhorning G, Balke K, Erpenbeck V J, Petschallies J, Hoymann H G, Fabel H, Krug N. Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge. Am J Respir Crit Care Med 1999; 159(6):1803–1809. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hite R D, Seeds M C, Jacinto R J, Goldsmith B G, Bowton D L, Waite B M, Bass D A. The spectrum of surfactant dysfunction in an endobronchial challenge model of asthma [abstract]. Am J Respir Crit Care Med 1999; 159:A333
   Web of Science ®Google Scholar
• Jarjour N N, Enhorning G. Antigen-induced airway inflammation in atopic subjects generates dysfunction of pulmonary surfactant. Am J Respir Crit Care Med 1999; 160(1):336–341. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Chaux G E, Smith R M, Walsh L, Ramsdell J, Spragg R G. A pilot study of the effects of aerosolized surfactant in stable asthmatics [abstract]. Am J Respir Crit Care Med 1997; 155:A215
   Google Scholar
• Oetomo S B, Dorrepaal C, Bos H, Gerritsen J, Van der Mark T W, Koeter G H, van Aalderen W M. Surfactant nebulization does not alter airflow obstruction and bronchial responsiveness to histamine in asthmatic children. Am J Respir Crit Care Med 1996; 153(3):1148–1152. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Liu M, Wang L, Li E, Enhorning G. Pulmonary surfactant given prophylactically alleviates an asthma attack in guinea-pigs. Clin Exp Allergy 1996; 26(3):270–275. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• McGill K, Sorkness C, Sorkness R, Brown D L, Busse W. A double-blind, randomized, placebo-controlled, crossover study of mutiple nebulized doses of Exosurf™ (EXO) in patients with mild to moderate asthma [abstract]. J Allergy Clin Immunol 1995; 95(part 2):S353
   Google Scholar
• Kurashima K, Ogawa H, Ohka T, Fujimura M, Matsuda T, Kobayashi T. A pilot study of surfactant inhalation in the treatment of asthmatic attack. Arerugi 1991; 40(2):160–163. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• in't Veen J C, Beekman A J, Bell E H, Sterk P J. Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes. Am J Respir Crit Care Med 2000; 161(6):1902–1906. [CSA]
   PubMed Web of Science ®Google Scholar
• Donnelly L F, MacFail J R, McAdams H P, Majure J M, Smith J, Frush D P, Bogonad P, Charles H C, Ravin C E. Cystic fibrosis: combined hyperpolarized 3He-enhanced and conventional proton MR imaging in the lung—preliminary observations. Radiology 1999; 212(3):885–889. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• King G G, Eberl S, Salome C M, Young I H, Woolcock A J. Differences in airway closure between normal and asthmatic subjects measured with single-photon emission computed tomography and technegas. Am J Respir Crit Care Med 1998; 158(6):1900–1906. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Seeds M C, Jones K A, Hite R D, Willingham M C, Borgerink H M, Woodruff R D, Bowton D L, Bass D A. Cell-specific expression of group X and group V secretory phospholipases A2 in human lung airway epithelial cells. Am J Respir Cell Mol Biol 2000; 23(1):37–44. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kim Y J, Kim K P, Han S K, Munoz N M, Zhu X, Sano H, Leff A R, Cho W. Group V phospholipase A2 induces leukotriene biosynthesis in human neutrophils through the activation of group IVA phospholipase A2. J Biol Chem 2002; 277(39):36479–36488. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kim K P, Rafter J D, Bittova L, Han S K, Snitko Y, Munoz N M, Leff A R, Cho W. Mechanism of human group V phospholipase A2 (PLA2)-induced leukotriene biosynthesis in human neutrophils. J Biol Chem 2001; 276(14):11126–11134. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Dente F L, Bacci E, DiFranco D, Conti I, Maccioni P, Scuotri L, Taccola M, Vagaggini B, Paggiaro P L. Reproducibility of early and late asthmatic responses to allergen challenge in a large group of asthmatics. Respir Med 2000; 94(5):441–447. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar